US OTC Nasal Product Firm Warned One Size Doesn’t Fit All Products For GMP Compliance

Expectation to use same manufacturing species for OTC nasal products with different active ingredients leads a list of quality-control problems FDA reported following an inspection of Profound Inc.

• Source: Shutterstock

More from Regulation

More from Policy & Regulation